share_log

The Consensus EPS Estimates For Yidu Tech Inc. (HKG:2158) Just Fell Dramatically

The Consensus EPS Estimates For Yidu Tech Inc. (HKG:2158) Just Fell Dramatically

醫渡科技(臨時代碼)的每股收益預估一致性(EPS)大幅下降。
Simply Wall St ·  07/02 18:46

The analysts covering Yidu Tech Inc. (HKG:2158) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.

今天,覆蓋着醫渡科技股份有限公司(港交所股票代號:2158)的分析師對今年的財務預測進行了大幅調整,給股東們帶來了消極的影響。營業收入和每股收益預測均有下調,分析師們看到了未來的不確定性。

Following the downgrade, the most recent consensus for Yidu Tech from its five analysts is for revenues of CN¥887m in 2025 which, if met, would be a solid 9.9% increase on its sales over the past 12 months. Losses are expected to be contained, narrowing 15% per share from last year to CN¥0.16 per share. Yet before this consensus update, the analysts had been forecasting revenues of CN¥1.0b and losses of CN¥0.082 per share in 2025. Ergo, there's been a clear change in sentiment, with the analysts administering a notable cut to this year's revenue estimates, while at the same time increasing their loss per share forecasts.

在此次下調之後,五位分析師對醫渡科技的最新共識是,到2025年,其營收將達到8.87億元人民幣,如果實現,則會較過去12個月的銷售額增長9.9%。預計虧損將得到控制,每股虧損將從去年的0.18元人民幣降至0.16元人民幣。而在此共識更新之前,分析師預測醫渡科技到2025年的營收將達到10億元人民幣,每股虧損爲0.082元人民幣。因此,分析師的情緒發生了明顯的變化,他們明顯地降低了今年的營收預測,同時增加了每股虧損的預測。

earnings-and-revenue-growth
SEHK:2158 Earnings and Revenue Growth July 2nd 2024
2024年7月2日,醫渡科技的盈利和營收增長

The consensus price target fell 6.2% to CN¥6.04, implicitly signalling that lower earnings per share are a leading indicator for Yidu Tech's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Yidu Tech at CN¥7.44 per share, while the most bearish prices it at CN¥4.82. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

共識價目標下降了6.2%至6.04元人民幣,這意味着每股收益較低是醫渡科技估值的一個主要指標。然而,還有一種觀點是,看看分析師提出的價目標範圍,因爲廣泛的估計範圍可能表明對業務可能結果的不同看法。目前,看好業務的分析師將醫渡科技的價格定在7.44元人民幣/股,而看淡業務的分析師則將價格定在4.82元人民幣/股。股票存在着不同的觀點,但是在我們看來,估計範圍不夠廣泛,不能說明形勢無法預測。

Of course, another way to look at these forecasts is to place them into context against the industry itself. We can infer from the latest estimates that forecasts expect a continuation of Yidu Tech'shistorical trends, as the 9.9% annualised revenue growth to the end of 2025 is roughly in line with the 9.5% annual revenue growth over the past five years. Compare this with the broader industry (in aggregate), which analyst estimates suggest will see revenues grow 20% annually. So it's pretty clear that Yidu Tech is expected to grow slower than similar companies in the same industry.

當然,查看這些預測的另一種方法是將其放在行業本身的背景下。我們可以從最新的預測中推斷,預計的Yidu Tech持續歷史趨勢,到2025年的年平均營收增長率與過去五年的9.5%年平均營收增長率大致相當。將其與更廣泛的行業(總體上)進行比較,分析師的估計顯示,行業的年營收增長率將達到20%。因此,很明顯,與同行業的其他公司相比,Yidu Tech的增長速度預計會更慢。

The Bottom Line

最重要的事情是分析師增加了它對下一年每股虧損的估計。令人欣慰的是,營收預測未發生重大變化,業務仍有望比整個行業增長更快。共識價格目標穩定在28.50美元,最新估計不足以對價格目標產生影響。

The most important thing to take away is that analysts increased their loss per share estimates for this year. Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. With a serious cut to this year's expectations and a falling price target, we wouldn't be surprised if investors were becoming wary of Yidu Tech.

最重要的是,分析師提高了他們今年的每股虧損預測。遺憾的是,他們也下調了他們的營收預測,最新的預測表明,業務增長速度將慢於更廣泛的市場。通過對今年的預期進行重大削減和目標股價下跌,我們不會驚訝如果投資者開始對醫渡科技產生警惕。

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for Yidu Tech going out to 2027, and you can see them free on our platform here.

儘管如此,公司的長期軌跡對於股東的價值創造來說更爲重要。在Simply Wall St上,我們對Yidu Tech的分析師預測進行了完整的範圍評估,涵蓋了到2027年的預測,並且您可以在此處免費查看這些預測。

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

跟蹤管理層是購買還是銷售,是尋找可能達到關鍵點的有趣公司的另一種方法,我們的免費公司列表由內部支持的增長公司組成。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論